Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Argus Health
Queensland Health
US Army

Generated: December 18, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Finasteride, and what generic alternatives are available?

Finasteride is a drug marketed by Accord Hlthcare, Actavis Totowa, Actavis Totowa Teva, Alkem Labs Ltd, Aurobindo Pharma, Aurobindo Pharma Ltd, Cipla Ltd, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Gedeon Richter Usa, Hetero Labs Ltd Iii, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sun Pharma Global, Teva, and Zydus Pharms Usa Inc. and is included in twenty-two NDAs.

The generic ingredient in FINASTERIDE is finasteride. There are fourteen drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the finasteride profile page.
Drug patent expirations by year for FINASTERIDE

Pharmacology for FINASTERIDE

Medical Subject Heading (MeSH) Categories for FINASTERIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord HlthcareFINASTERIDEfinasterideTABLET;ORAL091643-001Nov 5, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalFINASTERIDEfinasterideTABLET;ORAL090508-001Jul 1, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo PharmaFINASTERIDEfinasterideTABLET;ORAL078341-001Oct 30, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Totowa TevaFINASTERIDEfinasterideTABLET;ORAL077914-001Mar 28, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Gedeon Richter UsaFINASTERIDEfinasterideTABLET;ORAL077251-001Dec 22, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaFINASTERIDEfinasterideTABLET;ORAL076905-001Nov 5, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdFINASTERIDEfinasterideTABLET;ORAL203687-001Nov 5, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalFINASTERIDEfinasterideTABLET;ORAL090507-001Aug 16, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
MylanFINASTERIDEfinasterideTABLET;ORAL077578-001Dec 18, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiFINASTERIDEfinasterideTABLET;ORAL090061-001Jun 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Harvard Business School
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: